M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68%
Market Cap: 2.4B SAR
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Sep 30, 2024 596.5m
Jun 30, 2024 515.4m
Mar 31, 2024 507.6m
Dec 31, 2023 338.4m
0
Operating Income
+0%
Sep 30, 2024 122m
Jun 30, 2024 115.1m
Mar 31, 2024 111.4m
Dec 31, 2023 78.2m
0
Net Income
+0%
Sep 30, 2024 100.9m
Jun 30, 2024 97m
Mar 31, 2024 93.2m
Dec 31, 2023 65.8m

Earnings Waterfall
Middle East Pharmaceutical Industries Company SJSC

Revenue
596.5m SAR
Cost of Revenue
-231.5m SAR
Gross Profit
364.9m SAR
Operating Expenses
-242.9m SAR
Operating Income
122m SAR
Other Expenses
-21.2m SAR
Net Income
100.9m SAR

Income Statement
Middle East Pharmaceutical Industries Company SJSC

Rotate your device to view
Income Statement
Currency: SAR
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
338
N/A
508
+50%
515
+2%
596
+16%
Gross Profit
Cost of Revenue
(131)
(201)
(197)
(232)
Gross Profit
207
N/A
306
+48%
318
+4%
365
+15%
Operating Income
Operating Expenses
(129)
(195)
(203)
(243)
Selling, General & Administrative
(121)
(183)
(190)
(228)
Depreciation & Amortization
(8)
(12)
(12)
(15)
Other Operating Expenses
(0)
(1)
(1)
(0)
Operating Income
78
N/A
111
+42%
115
+3%
122
+6%
Pre-Tax Income
Interest Income Expense
(6)
(8)
(8)
(8)
Total Other Income
(1)
(2)
(2)
(2)
Pre-Tax Income
71
N/A
102
+43%
106
+4%
111
+5%
Net Income
Tax Provision
(6)
(9)
(9)
(10)
Income from Continuing Operations
66
93
97
101
Net Income (Common)
66
N/A
93
+42%
97
+4%
101
+4%
EPS (Diluted)
3.29
N/A
4.66
+42%
4.85
+4%
5.04
+4%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.